良性前列腺增生经尿道前列腺等离子电切术临床路径释义  

Clinical pathway interpretation of transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia

作　　者：阎思宇 黄兴 陈征[3] 杨璐 贾招辉[5] 彭谋[6] 任选义[7] 熊晶 李晓东[9] 徐晓峰 孙中义 王永博 李绪辉 胡万里 王婷[2] 靳英辉[1] 訾豪 刘同族 曾宪涛[1,2] 贺大林 王行环[2] 中国研究型医院学会泌尿外科学专业委员会[13] 中国医疗保健国际交流促进会循证医学分会[13] 国家重点研发计划微创等离子手术体系研发和产业化项目组 Si-Yu YAN;Xing HUANG;Zheng CHEN;Lu YANG;Zhao-Hui JIA;Mou PENG;Xuan-Yi REN;Jing XIONG;Xiao-Dong LI;Xiao-Feng XU;Zhong-Yi SUN;Yong-Bo WANG;Xu-Hui LI;Wan-Li HU;Ting WANG;Ying-Hui JIN;Hao ZI;Tong-Zu LIU;Xian-Tao ZENG;Da-Lin HE;Xing-Huan WANG;Urological Association of Chinese Research Hospital Association;Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care;Project Group for Minimally Invasive Plasmakinetic Surgery System Development and Industrialization of the National Key Research and Development Program(Center for Evidence-Based and Translational Medicine,Zhongnan Hospital of Wuhan University,Wuhan 430071,China;Department of Urology,Zhongnan Hospital of Wuhan University,Wuhan 430071,China;Department of Urology,The First Affiliated Hospital of Jinan University,Guangzhou 510630,China;Department of Urology,Institute of Urology,West China Hospital,Sichuan University,Chengdu 610041,China;Department of Urology,The First Affiliated Hospital of Henan University of Science and Technology,Luoyang 471003,Henan Province,China;Department of Urology,The Second Xiangya Hospital of Central South University,Changsha 410011,China;Department of Urology,Kaifeng Central Hospital,Kaifeng 475001,Henan Province,China;Department of Urology,The First Affiliated Hospital of Nanchang University,Nanchang 330006,China;Department of Urology,Huaihe Hospital of Henan University,Kaifeng 475000,Henan Province,China;Department of Urology,Xianyang Central Hospital,Xianyang 712000,Shannxi Province,China;Department of Urology,Shenzhen University General Hospital,Shenzhen 518055,China;Department of Urology,The First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061,China;不详)

机构地区：[1]武汉大学中南医院循证与转化医学中心,武汉430071 [2]武汉大学中南医院泌尿外科,武汉430071 [3]暨南大学附属第一医院泌尿外科,广州510630 [4]四川大学华西医院泌尿外科,成都610041 [5]河南科技大学第一附属医院泌尿外科,河南洛阳471003 [6]中南大学湘雅二医院泌尿外科,长沙410011 [7]开封市中心医院泌尿外科,河南开封475001 [8]南昌大学第一附属医院泌尿外科,南昌330006 [9]河南大学淮河医院泌尿外科,河南开封475000 [10]咸阳市中心医院泌尿外科,陕西咸阳712000 [11]深圳大学总医院泌尿外科,广东深圳518055 [12]西安交通大学第一附属医院泌尿外科,西安710061 [13]不详

出　　处：《医学新知》2022年第3期214-222,共9页New Medicine

基　　金：国家重点研发计划项目(科技助力经济2020、2016YFC0106300);国家发改委、国家卫健委疑难病症诊治能力提升工程项目(发改办社会[2018]347号);湖北省技术创新专项重大项目(2016ACA152)。

摘　　要：良性前列腺增生是引发中老年男性排尿功能障碍最为常见的一种良性疾病,也是导致下尿路症状的主要原因。经尿道前列腺等离子电切术效果好、安全可靠,已在临床中广泛应用。为进一步规范该手术的临床应用,国家卫生健康委员会于2019年首次发布了《良性前列腺增生经尿道前列腺等离子电切术临床路径》。鉴于临床路径的篇幅有限,本文以该路径为蓝本,遵照循证医学的思路与方法进行释义,旨在提供更为详尽的证据补充,以帮助医护人员和管理人员能更好地理解、把握和正确运用本临床路径。Benign prostatic hyperplasia is the most common benign disease that causes urination dysfunction in middle-aged and elderly men,and is also the main cause of lower urinary tract symptoms.Transurethral plasmakinetic resection of prostate has been widely used in clinical practice for its good efficacy and safety.In order to further standardize the clinical application of this surgery,the National Health Commission published the initial Clinical Pathway Interpretation of Transurethral Plasmakinetic Resection of Prostate for Benign Prostatic Hyperplasia in 2019.In view of the limited content of this clinical pathway,using it as a blueprint,we have interpreted it and applied the ideas and methods of evidence-based medicine,aiming to provide a more detailed evidence supplement to help medical staff and managers better understand,grasp and correctly use this clinical pathway.

关 键 词：临床路径 良性前列腺增生 下尿路症状 经尿道等离子电切术 等离子双极电切术 循证医学 

分 类 号：R699.8[医药卫生—泌尿科学]